Losortan Potassium
Product Images NDC 53002-5643

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losortan Potassium (NDC 53002-5643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Losapotatab1 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 01)

FDA Label Image

Losapotatab2 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 02)

FDA Label Image

Losapotatab3 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 03)

This text provides information about the effects of two medications, Atenolol and Losartan Potassium, on the risk of fatal/non-fatal stroke in patients. The adjusted risk reduction is 25% with a p-value of 0.001. The text also mentions a timeline or study month, but there is not enough context to determine its specific meaning.*

FDA Label Image

Losapotatab (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 04)

FDA Label Image

Losapotatab5 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 05)

FDA Label Image

Label Image (Lbl530025643)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.